Arkstone Launches Specialized COVID-19 Reports with Latest Treatments Guidelines

Arkstone Medical Solutions is joining the fight in the global pandemic by enhancing the already game-changing Arsktone report with real-time COVID-19 stats and the latest treatment recommendations from the CDC and FDA. The Arkstone Report, which presents physicians with a clear and easy to read analysis of laboratory results, is already in use by many molecular laboratories across the country. Each Arkstone Report includes Arkstone's proprietary OneChoice recommendation, which offers precision-guided treatment options, and the ArkScore, which takes recommendations a step further by offering providers an easy way to compare antibiotics to one another, as some are considerably safer and more effective than others. The report is also an important part of Antimicrobial Stewardship Programs in hundreds of skilled nursing facilities nationwide. The new COVID-19 Pandemic Alert section incorporates infection statistic information from Johns Hopkins University, specific to the location of the patient, to help keep providers informed of potential increases in infection rates. While no treatment or vaccine is yet available, the Arkstone Report continues to assist providers in making informed care decisions by including the latest treatment information at the time of the lab test. This information will be ever-evolving and be updated when new research or treatment options become available. “The more information a physician has at their fingertips the better,” says Arkstone’s co-founder, Dr. Ari Frenkel.